Our Healthcare News

Molecular Partners Wins European Biotechnica Award 2015

ZURICH, Switzerland—Molecular Partners AG (MOLN) announced today that it has been honored with the EUROPEAN BIOTECHNICA AWARD 2015. The award honors one company that has…  

Oct 07 2015

Elusys Awarded Additional $16 Million To Complete Development of Lyophilized Form of Anthim

PINE BROOK, New Jersey—Elusys Therapeutics, Inc. (Elusys) today announced it has been awarded $16 million of additional funding from the U.S. Government to further advance…  

Oct 06 2015

FDA Accepts NDA for Abilify with Ingestible Sensor

—Amanda Pedersen, Senior Staff Writer, Medical Device Daily, September 15th, 2015

Digital technology has advanced to the point of allowing pharmaceutical companies to make drugs…  

Sep 15 2015

Essex Woodlands Fund IX Acquires Significant Position in AxoGen, Inc.

ALACHUA, Florida—AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, has sold 4,861,111 registered shares of its…  

Aug 27 2015

Catalyst Biosciences Completes Merger with Targacept

SOUTH SAN FRANCISCO, California—(GLOBE NEWSWIRE)—Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel medicines to address serious medical conditions, today…  

Aug 20 2015

Entellus Medical Announces Collaboration with Fiagon

PLYMOUTH, Minnesota—Entellus Medical, Inc. (“Entellus Medical” or the “Company”) (NASDAQ: ENTL), a medical technology company focused on the design, development and commercialization of products for…  

Aug 10 2015

Corium Prices Follow-On Offering of Common Stock

MENLO PARK, California (GLOBE NEWSWIRE)—Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced…  

Aug 05 2015

Abiomed Announces Q1 FY 2016 Revenue of $73.4 Million, Up 50% Over Prior Year

DANVERS, Massachusetts—Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2016 revenue of $73.4 million, an increase…  

Aug 04 2015

Entellus Medical Announces Positive 24 Month Data from Remodel Trial, Meta-Analysis Across 6 Studies

PLYMOUTH, Minnesota—Entellus Medical, Inc. (NASDAQ: ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in…  

Jul 31 2015